Auro Laboratories [AUROLAB] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Auro Laboratories

BSE

Sequent Scientific

NSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Auro Laboratories wins in 8 metrics, Sequent Scientific wins in 9 metrics, with 0 ties. Sequent Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Auro Laboratories	Sequent Scientific	Better
P/E Ratio (TTM)	85.07	153.95	Auro Laboratories
Price-to-Book Ratio	3.65	6.28	Auro Laboratories
Debt-to-Equity Ratio	104.76	62.47	Sequent Scientific
PEG Ratio	N/A	1.29	N/A
EV/EBITDA	98.60	29.43	Sequent Scientific
Profit Margin (TTM)	5.96%	1.85%	Auro Laboratories
Operating Margin (TTM)	-8.69%	7.56%	Sequent Scientific
EBITDA Margin (TTM)	N/A	7.56%	N/A
Return on Equity	4.28%	2.84%	Auro Laboratories
Return on Assets (TTM)	1.86%	1.37%	Auro Laboratories
Free Cash Flow (TTM)	$-180.54M	$442.73M	Sequent Scientific
1-Year Return	27.16%	5.57%	Auro Laboratories
Price-to-Sales Ratio (TTM)	9.51	2.76	Sequent Scientific
Enterprise Value	$2.08B	$48.87B	Sequent Scientific
EV/Revenue Ratio	12.65	3.05	Sequent Scientific
Gross Profit Margin (TTM)	31.59%	46.86%	Sequent Scientific
Revenue per Share (TTM)	$26	$64	Sequent Scientific
Earnings per Share (Diluted)	$2.95	$1.15	Auro Laboratories
Beta (Stock Volatility)	0.20	0.91	Auro Laboratories

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Auro Laboratories vs Sequent Scientific Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Auro Laboratories	-3.32%	-2.98%	-9.91%	0.49%	10.14%	-2.74%
Sequent Scientific	-0.15%	-0.44%	-6.77%	-2.09%	9.71%	-5.23%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Auro Laboratories	27.16%	230.13%	351.23%	1,605.67%	5,058.27%	3,066.46%
Sequent Scientific	5.57%	52.75%	30.80%	19.46%	19.46%	19.46%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Auro Laboratories (AUROLAB): View Full Stock Overview

Sequent Scientific (SEQUENT): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Auro Laboratories vs Sequent Scientific

Metric	AUROLAB	SEQUENT
Market Information
Market Cap i	₹1.56B	₹44.30B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	4,233	688,982
90 Day Avg. Volume i	6,076	534,520
Last Close	₹247.35	₹175.85
52 Week Range	₹170.00 - ₹303.00	₹117.35 - ₹240.70
% from 52W High	-18.37%	-26.94%
All-Time High	₹307.20 (May 06, 2024)	₹336.50 (Jun 28, 2021)
% from All-Time High	-19.48%	-47.74%
Growth Metrics
Quarterly Revenue Growth	-0.52%	0.13%
Quarterly Earnings Growth	-0.32%	1.20%
Financial Health
Profit Margin (TTM) i	0.06%	0.02%
Operating Margin (TTM) i	-0.09%	0.08%
Return on Equity (TTM) i	0.04%	0.03%
Debt to Equity (MRQ) i	104.76	62.47
Cash & Liquidity
Book Value per Share (MRQ)	₹68.67	₹28.19
Cash per Share (MRQ)	₹1.02	₹2.52
Operating Cash Flow (TTM) i	₹74.16M	₹360.47M
Levered Free Cash Flow (TTM) i	₹18.39M	₹218.78M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	₹0.00

Valuation & Enterprise Metrics Analysis: Auro Laboratories vs Sequent Scientific

Metric	AUROLAB	SEQUENT
Price Ratios
P/E Ratio (TTM) i	85.07	153.95
Forward P/E i	N/A	35.06
PEG Ratio i	N/A	1.29
Price to Sales (TTM) i	9.51	2.76
Price to Book (MRQ) i	3.65	6.28
Market Capitalization
Market Capitalization i	₹1.56B	₹44.30B
Enterprise Value i	₹2.08B	₹48.87B
Enterprise Value Metrics
Enterprise to Revenue i	12.65	3.05
Enterprise to EBITDA i	98.60	29.43
Risk & Other Metrics
Beta i	0.20	0.91
Book Value per Share (MRQ) i	₹68.67	₹28.19

Financial Statements Comparison: Auro Laboratories vs Sequent Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	AUROLAB	SEQUENT
Revenue/Sales i	₹75.40M	₹4.41B
Cost of Goods Sold i	₹51.58M	₹2.35B
Gross Profit i	₹23.82M	₹2.07B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹6.47M	₹333.50M
EBITDA i	₹9.19M	₹505.30M
Pre-Tax Income i	₹3.29M	₹255.20M
Income Tax i	₹-3.49M	₹79.50M
Net Income (Profit) i	₹6.77M	₹175.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	AUROLAB	SEQUENT
Cash & Equivalents i	₹3,000	₹626.60M
Total Current Assets i	₹215.14M	₹8.74B
Total Current Liabilities i	₹216.42M	₹5.05B
Long-Term Debt i	₹330.85M	₹3.00B
Total Shareholders Equity i	₹429.68M	₹7.70B
Retained Earnings i	N/A	₹1.25B
Property, Plant & Equipment i	₹210.58M	₹2.84B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	AUROLAB	SEQUENT
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	AUROLAB	SEQUENT
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	4,233	688,982
Average Daily Volume (90 Day) i	6,076	534,520
Shares Outstanding i	6.23M	249.89M
Float Shares i	2.50M	117.77M
% Held by Insiders i	0.60%	0.53%
% Held by Institutions i	0.00%	0.13%

Dividend Analysis & Yield Comparison: Auro Laboratories vs Sequent Scientific

Metric	AUROLAB	SEQUENT
Last 12-Month Dividend i	N/A	₹0.00
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	₹0.00
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	₹0.00
Ex-Dividend Date	N/A	N/A

Auro Laboratories [AUROLAB] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison